Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of MR Vaccine in Indonesian Children
NCT03680417Phase 4Completed
- Sponsor
- Bio Farma
- Start
- Nov 2017
- Primary completion
- Feb 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Measles rubella vaccine in measles, rubella, sponsored by Bio Farma. Started Nov 2017; status: completed.
02
Drugs
Measles rubella vaccine
03
Conditions
measlesrubella
Beyond the preview
Go deeper on NCT03680417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03680417.